Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients

Table 3

Central foveal thickness in both groups.

CFT	Baseline	1 month	2 months	4 months	6 months
Nepafenac group (μm) mean ± SD	191.63 ± 8.82	200.44 ± 9.56	205.56 ± 9.44	208.22 ± 9.91	210.85 ± 11.11
Control group (μm) mean ± SD	182.68 ± 9.55	204.18 ± 10.90	210.25 ± 13	219.68 ± 16.42	228 ± 19.79
value	0.091	0.219	0.111	0.003	0.0023

CFT: central foveal thickness.